| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 2,4 M € | — | — | — | — | — | ||||||||||||||
| Gross margin | -9,8 k € | -106.1% | 160,8 k € | -76.9% | 695,8 k € | -24.4% | 920,7 k € | -28.7% | 1,3 M € | +106.6% | 624,9 k € | +9.4% | 571,4 k € | -3.0% | 589,1 k € | +279.8% | 155,1 k € | +379.5% | -55,5 k € | -160.9% | 91,1 k € | +62.4% | 56,1 k € | +1747.8% | 3,0 k € | -99.4% | 471,1 k € | |
| EBITDA | -14,5 k € | -113.9% | 104,1 k € | -61.8% | 272,5 k € | -32.6% | 404,2 k € | -49.1% | 794,1 k € | +238.2% | 234,8 k € | +38.3% | 169,8 k € | -38.5% | 276,3 k € | +572.6% | -58,5 k € | +60.6% | -148,3 k € | -18085.3% | -815,4 € | +97.2% | -28,9 k € | +63.3% | -78,7 k € | -162.8% | 125,4 k € | |
| Operating profit | -62,0 k € | -35.6% | -45,7 k € | -167.1% | 68,1 k € | -73.9% | 261,1 k € | -59.1% | 638,7 k € | +863.5% | 66,3 k € | +217.0% | 20,9 k € | -81.1% | 110,5 k € | +190.4% | -122,2 k € | +46.3% | -227,5 k € | -613.7% | -31,9 k € | +50.6% | -64,5 k € | +46.0% | -119,4 k € | -238.7% | 86,1 k € | |
| Profit/loss | -92,6 k € | -51.0% | -61,3 k € | -204.7% | 58,6 k € | -76.2% | 246,3 k € | -60.5% | 623,6 k € | +1060.6% | 53,7 k € | +586.2% | 7,8 k € | -92.3% | 102,0 k € | +147.7% | -213,7 k € | +9.9% | -237,1 k € | -464.2% | -42,0 k € | +38.6% | -68,4 k € | +78.2% | -313,3 k € | -887.0% | 39,8 k € | |
| Equity | 1,0 M € | -8.2% | 1,1 M € | -5.1% | 1,2 M € | +5.2% | 1,1 M € | +27.7% | 889,5 k € | +234.5% | 265,9 k € | +25.3% | 212,2 k € | +3.8% | 204,3 k € | +162.7% | -325,6 k € | -190.9% | -111,9 k € | -189.5% | 125,1 k € | -25.1% | 167,1 k € | -29.0% | 235,6 k € | -57.1% | 548,8 k € | |
| Total assets | 2,0 M € | +23.0% | 1,6 M € | -36.8% | 2,6 M € | +1.3% | 2,6 M € | +54.2% | 1,7 M € | +23.7% | 1,3 M € | +13.9% | 1,2 M € | -18.1% | 1,4 M € | +35.7% | 1,1 M € | -8.6% | 1,2 M € | +133.8% | 495,5 k € | -11.0% | 556,9 k € | -24.5% | 737,8 k € | -78.3% | 3,4 M € | |
| Cash | 1,2 k € | -89.9% | 11,6 k € | -80.9% | 60,8 k € | +107.9% | 29,3 k € | -92.4% | 385,5 k € | +797.3% | 43,0 k € | -32.8% | 63,9 k € | +0.6% | 63,5 k € | -30.3% | 91,2 k € | -52.3% | 191,1 k € | -20.9% | 241,5 k € | +1194.8% | 18,7 k € | -9.3% | 20,6 k € | -94.3% | 362,7 k € | |
| Debts | 969,3 k € | +95.6% | 495,6 k € | -64.4% | 1,4 M € | -1.9% | 1,4 M € | +84.9% | 767,7 k € | -28.1% | 1,1 M € | +10.5% | 965,3 k € | -21.2% | 1,2 M € | -11.6% | 1,4 M € | +9.0% | 1,3 M € | +254.6% | 358,3 k € | -5.3% | 378,3 k € | -14.2% | 440,9 k € | -84.2% | 2,8 M € | |
| Staff | — | 3,1 | 9,3 | 12,8 | 12 | 9,9 | 8,7 | 7,8 | 4,8 | 1,7 | 1,5 | 1,5 | 1,5 | 9,2 | ||||||||||||||
Public limited company · Zuienkerke · incorporated on 29/05/1985
Public limited company loss-making in the latest fiscal year. Cash position declining (-89.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Pharma2Care is a Public limited company incorporated in 1985. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Zuienkerke.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette